These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34153775)

  • 21. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.
    Perry JA; Kiezun A; Tonzi P; Van Allen EM; Carter SL; Baca SC; Cowley GS; Bhatt AS; Rheinbay E; Pedamallu CS; Helman E; Taylor-Weiner A; McKenna A; DeLuca DS; Lawrence MS; Ambrogio L; Sougnez C; Sivachenko A; Walensky LD; Wagle N; Mora J; de Torres C; Lavarino C; Dos Santos Aguiar S; Yunes JA; Brandalise SR; Mercado-Celis GE; Melendez-Zajgla J; Cárdenas-Cardós R; Velasco-Hidalgo L; Roberts CW; Garraway LA; Rodriguez-Galindo C; Gabriel SB; Lander ES; Golub TR; Orkin SH; Getz G; Janeway KA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5564-73. PubMed ID: 25512523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
    Liu W; Cheng H; Huang Z; Li Y; Zhang Y; Yang Y; Jin T; Sun Y; Deng Z; Zhang Q; Lou F; Cao S; Wang H; Niu X
    Mol Oncol; 2024 Apr; 18(4):939-955. PubMed ID: 37727135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
    Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
    J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
    Smida J; Xu H; Zhang Y; Baumhoer D; Ribi S; Kovac M; von Luettichau I; Bielack S; O'Leary VB; Leib-Mösch C; Frishman D; Nathrath M
    Int J Cancer; 2017 Aug; 141(4):816-828. PubMed ID: 28494505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel.
    Guimarães GM; Tesser-Gamba F; Petrilli AS; Donato-Macedo CRP; Alves MTS; de Lima FT; Garcia-Filho RJ; Oliveira R; Toledo SRC
    Cancer Genet; 2021 Nov; 258-259():85-92. PubMed ID: 34666222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization.
    Yi GZ; Zhu TC; Que TS; Li ZY; Huang GL
    BMC Neurol; 2022 Oct; 22(1):390. PubMed ID: 36271359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases.
    Heczko L; Hlaváč V; Holý P; Dvořák P; Liška V; Vyčítal O; Fiala O; Souček P
    Cancer Cell Int; 2023 Nov; 23(1):295. PubMed ID: 38008721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The insertion and dysregulation of transposable elements in osteosarcoma and their association with patient event-free survival.
    Wang C; Liang C
    Sci Rep; 2022 Jan; 12(1):377. PubMed ID: 35013466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers.
    Cho SY; Chae J; Na D; Kang W; Lee A; Min S; Kang J; Choi B; Lee J; Sung CO; Chuang JH; Lee C; Lee WS; Park H; Kim JI
    Clin Cancer Res; 2019 May; 25(9):2821-2834. PubMed ID: 30670495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer.
    Kaur P; Campo D; Porras TB; Ring A; Lu J; Chairez Y; Su Y; Kang I; Lang JE
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
    Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
    Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
    Chen X; Bahrami A; Pappo A; Easton J; Dalton J; Hedlund E; Ellison D; Shurtleff S; Wu G; Wei L; Parker M; Rusch M; Nagahawatte P; Wu J; Mao S; Boggs K; Mulder H; Yergeau D; Lu C; Ding L; Edmonson M; Qu C; Wang J; Li Y; Navid F; Daw NC; Mardis ER; Wilson RK; Downing JR; Zhang J; Dyer MA;
    Cell Rep; 2014 Apr; 7(1):104-12. PubMed ID: 24703847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy.
    Kuijjer ML; van den Akker BE; Hilhorst R; Mommersteeg M; Buddingh EP; Serra M; Bürger H; Hogendoorn PC; Cleton-Jansen AM
    BMC Med Genomics; 2014 Jan; 7():4. PubMed ID: 24447333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
    Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
    Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
    Du X; Yang J; Yang D; Tian W; Zhu Z
    BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiered analysis of whole-exome sequencing for epilepsy diagnosis.
    Dunn PJ; Maher BH; Albury CL; Stuart S; Sutherland HG; Maksemous N; Benton MC; Smith RA; Haupt LM; Griffiths LR
    Mol Genet Genomics; 2020 May; 295(3):751-763. PubMed ID: 32146541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.